The Use of Extracorporeal Membrane Oxygenation as a Bridge to Bone Marrow Transplantation in a Patient With High-risk Acute Myeloid Leukemia.
| Autor: | Nader M; Department of Pediatrics, Section of Critical Care Medicine, Yale New Haven Children's Hospital., Bonde P; Department of Surgery, Section of Cardiac Surgery., Massaro S; Department of Pediatrics, Section of Pediatric Hematology and Oncology., Giuliano JS Jr; Department of Pediatrics, Section of Critical Care Medicine, Yale University School of Medicine, New Haven, CT., Shah N; Department of Pediatrics, Section of Pediatric Hematology and Oncology. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2023 Jan 01; Vol. 45 (1), pp. 18-20. Date of Electronic Publication: 2022 Oct 10. |
| DOI: | 10.1097/MPH.0000000000002567 |
| Abstrakt: | An 18-year-old girl with high-risk acute myeloid leukemia developed Streptococcus mitis septic shock and multiorgan dysfunction syndrome, including biventricular failure. Due to the anticipated reversibility of her cardiogenic shock, her young age, and her favorable survival chance after an allogeneic hematopoietic stem cell transplant, she was placed on full circulatory support with venoarterial extracorporeal membrane oxygenation as a bridge to her successful hematopoietic stem cell transplantation 2 months later. This highlights the importance of prognostication in patient selection for extracorporeal life support. A multidisciplinary approach is essential to each case until more definite initiation criteria, risk stratification, and treatment protocols are established. Competing Interests: The authors declare no conflict of interest (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|